| COMPOSITION: | Each film coated tablet contains Empagliflozin 12.5 mg & Metformin hydrochloride 1000 mg |
| FORMULATION: | TABLETS |
| STATUS: | PRESCRIPTION ONLY DRUG |
| DESCRIPTION: | EMPAFORD 12.5 M FORTE is a fixed-dose combination of Empagliflozin, a selective SGLT2 inhibitor, and Metformin ER, a biguanide. This dual therapy provides effective glycaemic control in Type 2 Diabetes Mellitus by reducing glucose reabsorption in the kidneys and improving insulin sensitivity. The extended-release form of Metformin ensures better gastrointestinal tolerance and sustained action. |
| SIDE EFFECTS: | Nausea, vomiting, diarrhoea, abdominal pain, loss of appetite |
| DOSAGE/DIRECTIONS FOR USE: | As Prescribed by Physician |
